Biospecimen procurement for immunologic correlates in cancer
- Clements University Hospital
- Parkland Health & Hospital System
- Simmons Cancer Center Fort Worth
- UT Southwestern Ambulatory Services
- Zale Lipshy University Hospital
David Gerber, M.D.
Patients with an established cancer diagnosis and normal controls will be recruited. Following enrollment, a baseline assessment will be done. Tissue and/or blood and data will be collected from the participant and their medical record. each treating physician may set a follow-up schedule appropriate for the participant's condition and data will be collected from standard of care follow-up appointments.
Medical waste (surgical waste, venous blood, urine, bone marrow, and other blody fulids) may be collected at the time of a planned surgical procedure. Samples collected are excess or obtained as part of routine surgical care or diagnostic procedures. additional blood samples may be collected with optional consent.
Inclusion Criteria- Patients with known Cancer
1.1 Prior to study interventions and study enrollment all subjects must sign an informed consent indicating that they are aware of the investigational nature of this study. Subjects must have signed an authorization for the release of their protected health information.
1.2 Subject must be greater than 18 years of age.
1.3 Subjects must be willing to provide blood samples as biospecimens for the study.
NOTE: Patients enrolled on this protocol are not excluded from participation in other clinical trials